MBX Biosciences, Inc. Common Stock (MBX) NASDAQ
28.70
-1.04(-3.50%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
28.70
-1.04(-3.50%)
Currency In USD
| Market Cap | 1.15B |
| Enterprise Value | 1.08B |
| P/E Ratio | -12.05 |
| PEG Ratio | 14.4 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.84 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -9.31 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.23 |
| Return On Equity | -0.29 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -248,000 |
| EBITDA | -98.06M |
| Net Income | -86.97M |
| Diluted EPS | -2.38 |
| Total Cash | 373.71M |
| Total Cash/Share | 10.24 |
| Total Debt | 596,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 24.62 |
| Book Value Per Share | 10.11 |
| 52-Week Change | 241.67 |
| 52-Week High | 44.89 |
| 52-Week Low | 4.81 |
| Moving Average 50 Days | 35.18 |
| Moving Average 200 Days | 22.26 |
| Average Volume | 647,050 |
| Shares Outstanding | 33.59M |
| % Held by Institutions | 141.61 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |